Rhinoconjunctivitis Clinical Trials

51 clinical trials for Rhinoconjunctivitis across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df — RECRUITING · PHASE3
• Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. — RECRUITING · PHASE3
• Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites — RECRUITING · PHASE3
• Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen — RECRUITING · PHASE3
• Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte — COMPLETED
• Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. — COMPLETED · PHASE4
• A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment — COMPLETED · NA
• Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study — COMPLETED · PHASE1
• Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen — COMPLETED · PHASE3
• Intervention in Chronic Pediatric Patients and Their Families. — COMPLETED · NA
• Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy — COMPLETED · PHASE2
• Study to Evaluate the Efficacy and Safety of "Allergovac Poliplus" in Polysensitized Patients With Allergic Rhinitis/Rhinoconjunctivitis, With or Without Asthma — COMPLETED
• Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber — COMPLETED · NA
• Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy — OTHER · PHASE2
• PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm) — COMPLETED · PHASE2
• Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice — COMPLETED
• Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects — COMPLETED · NA
• Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma — COMPLETED · PHASE2
• Phase III Cat-PAD Study — COMPLETED · PHASE3
• Phase II HDM-SPIRE Safety and Efficacy Study — COMPLETED · PHASE2
• Paediatric Safety Study in Cat-PAD — COMPLETED · PHASE2
• Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without Asthma — TERMINATED · PHASE2
• A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea — COMPLETED · PHASE1
• A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria Judaica — COMPLETED · PHASE1
• Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) — COMPLETED · PHASE3
• Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) — COMPLETED · PHASE2
• Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) — COMPLETED · PHASE3
• Ragweed-SPIRE Follow-On Study — COMPLETED
• Efficacy Study of a Preseasonal Treatment With AllerT in Subjects With Birch Pollen Allergy — COMPLETED · PHASE2
• Grass Observational Study — COMPLETED
• ToleroMune Grass Follow on Study — COMPLETED
• 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma — COMPLETED · PHASE3
• ToleroMune House Dust Mite (HDM) Tolerability Study — COMPLETED · PHASE2
• An Optional Investigation of Biomarkers of Efficacy — COMPLETED
• House Dust Mite Observational Study — COMPLETED
• ToleroMune House Dust Mite Follow on Study — COMPLETED
• Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml). — COMPLETED · PHASE2
• ToleroMune Grass Follow on Study — COMPLETED
• Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma — COMPLETED · PHASE3
• ToleroMune Grass Exposure Unit Study — COMPLETED · PHASE2
• ToleroMune House Dust Mites (HDM) Exposure Chamber Study — COMPLETED · PHASE2
• Ocular Allergy Treatment Practical Impact Trial — OTHER · PHASE4
• Open Label Safety Study of a Birch Pollen Allergen Extract — COMPLETED · PHASE2
• Multicenter Trial of Immunotherapy With House Dust Mite Allergoid — COMPLETED · PHASE3
• An Optional Two Year Follow Up Study to Study CP005A — COMPLETED
• ToleroMune Ragweed Follow up Study — COMPLETED
• Cat-PAD Follow on Study — COMPLETED
• Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT) — COMPLETED · PHASE3
• Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy — COMPLETED · PHASE2
• Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis — COMPLETED · PHASE2

Refine this search